Veriphi is an innovative medical device company that has developed a solution to verify intravenous drug identity and concentration.
Globally, the cost associated with medication errors has been estimated to be US$42 billion per year. (WHO, Global Patient Safety Challenge: Medication Without Harm, 2017). Veriphi’s initial target market is intravenous oncology errors because intravenous errors are twice as likely to harm patients than drugs administered by other routes.
The heart of our solution is an analyser that uses lasers to verify intravenous drug identity and concentration. Veriphi has been granted 8 US patents and 22 global patents.
The Veriphi solution has applications inside the compounding pharmacy, in hospitals and at the patient’s bedside, wherever that may be.
Our objective is to make intravenous cancer therapy safer, more effective, more affordable and more accessible. We believe that access to cancer treatment should not be dictated by where you live.
Company Details
- Employees
- 13
- Address
- Po Box 32 – 525, Devonport,auckland 0744,new Zealand
- Phone
- 514-980-2751
- co****@****iphi.io
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- veriphi.co.nz
- HQ
- Devonport, Auckland
Veriphi Questions
Veriphi's helpline number is 514-980-2751
Veriphi's website is veriphi.co.nz
Veriphi's LinkedIn profile is https://nz.linkedin.com/company/veriphi
Veriphi has
13 employees.
View email and phone details for 13
employees at Veriphi.
Veriphi's industry is
Medical Equipment Manufacturing
Veriphi's top competitors are
Jacinta Fox,
Strategic Defence,
Vernalis,
Anthropic,
Intdevice,
Decision Lab Ltd,
Avasa,
Veriphi,
Endo Sport Nz,
Technology Investment Network.
Veriphi's support email address is contact@veriphi.io
Veriphi's categories are Medical Equipment Manufacturing
